The Zhou lab studies the pancreatic insulin-secreting beta-cells and the gut stem cells.

Weill Cornell Medical College
Joined October 2021
Please join us as we celebrate the life and legacy of Dr. Joe Q. Zhou...
59
ASGCT (American Society of Gene & Cell Therapy) 2023 Annual Meeting in Los Angeles
5
339
Paper online! Read my latest #research on restoring homeostasis with gastric insulin-secreting (#GINS) #organoids. It's about a novel #Autologous #CellTherapy for #diabetes, published with @SpringerNature in @NatureCellBio. Read here: rdcu.be/daThi
1
2
7
417
We presented our works at Keystone Stem Cells and Organoids Joint Meeting zhoulab.weill.cornell.edu/ne…
1
189
Congratulations to Steve on his paper in Nature Cell Biology! An important step (milestone) toward generating personalized cell therapy to treat type 1 and type 2 diabetes.
Our manuscript was accepted by NCB! In this study, we developed a robust 3-step protocol to induce cultured human gastric stem cells (hGSCs) from multiple donors to differentiate into functional islet-like gastric insulin-secreting (GINS) organoids. (1/8) biorxiv.org/content/10.1101/…
1
4
12
9,772
Dr. Xiaofeng Steve Huang @XfSteveHuang presented his work “Restoring Glucose Homeostasis with Stomach-derived Human Insulin-Secreting Organoids” in 2022 Annual Investigator Hybrid Meeting of Human Islet Research Network (HIRN).
Thank you to all HIRN members that participated our latest meeting. It was great seeing so many in person & online for #HIRN2022 Our membership reflects a wide variety of research specialities, experiences, and techniques yet all are committed to #diabetes #T1D #T2D research.
2
Joe Zhou and Remi Creusot organized the 2nd Symposium of the NYC*T1D Network (Type 1 Diabetes in New York City) at the New York Stem Cell Foundation. We have over 20 laboratories and 3 foundations participating. #Type1Diabetes #NYC #StemCells
5
Congratulations to Steve @XfSteveHuang ! He won the second place of oral presentation in Postdoc Research Day 2022!
Replying to @WCMPostdocs
🗣📊 Dr. Xiaofeng (Steve) Huang @XfSteveHuang, Postdoctoral Associate in Medicine in the @JoeZhouLab at @WeillCornell, told us about his research on stomach-derived human organoids that can be used as a potential cell-based therapy for the treatment of diabetes.
1
Dr. Joe Zhou presented Dr. Wei Gu's work @weill35770177 "SATB2 controls colon vs small intestine stem cell identity" in Gordon Research Conference
Dr. Xiaofeng Huang @XfSteveHuang presented his work "Redirecting differentiation of human stomach stem cells to produce pancreatic islet-like organoids for diabetes treatment" in Gordon Research Conference
3
Joe Zhou Lab retweeted
Our President and CEO, Jo Wiederhorn, urges Gov. Kathy Hochul to re-establish the critical #NYSTEM research program in this @CrainsNewYork op-ed: bit.ly/3Iegm2g @GovKathyHochul
Op-ed: The governor should re-establish state's defunded stem cell science program. To be a hub for life sciences and benefit from economic development this sector provides, New York must invest in research, not cut it ow.ly/kBeq103brFw
New Article online now CellStemCell: SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling zpr.io/i7J8gTxEnskY
1
6
7
Joe Zhou Lab retweeted
Xiaofeng Huang is a Postdoc: His current research goal is to develop a technology to derive large numbers of functional insulin-secreting cells from the abundant renewable sources of human gastric stem cells to treat Type 1 Diabetes. #HIRN2021Scholarship
1
3
20